Study guide

5.2 Electrical Stimulation, Ultrasound, and Topical Adjuncts

Wound Care Certified WCC

Track your progress as you read

Finished sections get a check mark.

1 Orientation: NAWCO WCC Exam, Eligibility, and Scoring

1.1 Credential Purpose, Sponsor, and Scope 1.2 Qualifying License and Eligibility Frame 1.3 Education and Experience Pathways 1.4 Exam Format, Delivery, and Timing 1.5 Scoring, Standard Setting, and Confidentiality 1.6 Fees, Scheduling, Retesting, and Recertification

2 Wound Assessment: Etiology, Status, and Skin Integrity

2.1 Assessment Domain and Exam Approach 2.2 Etiology Patterns and Location Clues 2.3 Wound Status: Measurement, Tissue, and Exudate 2.4 Depth, Tissue Loss, and Pressure Injury Language 2.5 Skin Structure, Function, and Barrier 2.6 Skin Integrity Across the Lifespan

3 Patient Assessment: Labs, Nutrition, Pain, and Risk Tools

3.1 Labs and Diagnostic Data in Wound Assessment 3.2 Nutrition, Hydration, and Healing Risk 3.3 Comorbidities, Medications, and Current Condition 3.4 Psychosocial History, Adherence Barriers, and Access 3.5 Pain Assessment Tools and Treatment Tolerance 3.6 Risk Tools, Cognition, Function, and ADLs

4 Treatment Foundations, Dressings, and Wound Bed Preparation

4.1 Cleansing, Wound Hygiene, and Assessment Before Treatment 4.2 Moisture Balance and Core Dressing Functions 4.3 Dressing Categories, Formulary, and Resource Fit 4.4 Periwound Protection, Exudate, and Securement 4.5 Wound Bed Preparation and Debridement Concepts 4.6 Infection Signs, Prevention, and Escalation

5 Advanced Therapies, Diagnostics, Support Surfaces, and Referrals

5.1 Negative Pressure Wound Therapy Readiness and Monitoring 5.2 Electrical Stimulation, Ultrasound, and Topical Adjuncts 5.3 Diagnostics, Cultures, Labs, and Referral Triggers 5.4 Support Surfaces, Pressure Redistribution, and Microclimate 5.5 Offloading, Compression, and Lymphedema Decision-Making 5.6 Hyperbaric Oxygen and Specialty Referral Coordination

6 Infection, Vascular, Diabetic, and Pressure Injury Scenarios

6.1 Local, Spreading, and Systemic Infection Signals 6.2 Biofilm, Colonization, Culture, and Antimicrobial Traps 6.3 Diabetic Foot Ulcer Scenarios: Neuropathy, Perfusion, and Offloading 6.4 Venous, Arterial, and Mixed Vascular Wound Scenarios 6.5 Pressure Injury Prevention, Staging, and Treatment Scenarios 6.6 Integrated Contraindication and Priority Scenarios

7 Reevaluation, Healing Progression, and Treatment Adjustment

7.1 Re-Evaluation Domain and Decision Cycle 7.2 Treatment Choice and Plan Effectiveness 7.3 Weekly Measurement and Trend Monitoring 7.4 Tolerance, Pain, and Treatment Reactions 7.5 Adherence Barriers and Plan Adjustment 7.6 Healing Phases and Progression Decisions

8 Education, Health Literacy, and Interprofessional Teaching

8.1 Education Domain Scope and Priorities 8.2 Patient and Family Treatment-Plan Teaching 8.3 Health Literacy, Plain Language, and Teach-Back 8.4 Language, Cognition, Sensory Needs, and Cultural Adaptation 8.5 Discharge Teaching and Home Adherence 8.6 Interprofessional Team Teaching and Prevention Reinforcement

9 Administration, Protocols, Data Quality, and Care Coordination

9.1 Administration Domain Map for WCC Candidates 9.2 Evidence-Based Protocols and Facility Processes 9.3 Formularies, Product Access, and Treatment-Plan Workflow 9.4 Educational Media and Team Communication Tools 9.5 Data Quality, Prevalence, Incidence, and Outcome Monitoring 9.6 Payers, Case Management, and Transition Coordination

10 Legal Documentation, Ethics, Scope, and Patient Autonomy

10.1 Legal Domain Map for WCC Candidates 10.2 Objective Wound-Characteristic Documentation 10.3 Treatment-Plan Documentation and Continuity 10.4 Scope of Practice, Regulatory Issues, and Consultation 10.5 Ethics, Culture, Palliative Care, and Patient Autonomy 10.6 Confidentiality, Record Integrity, and Exam Conduct

11 Risk, Prevention, At-Risk Populations, and Product Selection

11.1 Risk Framework for Impaired Skin Integrity 11.2 Pressure Prevention, Repositioning, and Support Surfaces 11.3 Moisture, Incontinence, and Periwound Protection 11.4 Offloading, Foot Risk, and At-Risk Populations 11.5 Product Indications, Contraindications, and Selection 11.6 Population-Specific Prevention Across Settings

12 Integrated WCC Case Scenarios and Final Review

12.1 Blueprint-Weighted Final Review Strategy 12.2 Integrated Pressure Injury Case Review 12.3 Integrated Diabetic Foot and Vascular Case Review 12.4 Integrated Venous Leg Ulcer and Compression Case Review 12.5 Legal, Education, and Administration Integrated Cases 12.6 Exam Day, Scoring, Retake, and Recertification Review

5.2 Electrical Stimulation, Ultrasound, and Topical Adjuncts

Key Takeaways Explain This Topic AI

Adjunctive therapies are selected only after wound etiology, wound bed status, contraindications, and facility policy are addressed.

Electrical stimulation and ultrasound items test indication, scope, implanted-device and malignancy cautions, sensation, patient tolerance, and reassessment.

Topical adjuncts do not replace cleansing, moisture balance, debridement, pressure control, or infection workup; antimicrobials need a stop point.

The trap is using an adjunct as a universal rescue for a stalled wound without first asking why healing stalled.

Last updated: June 2026

Adjunctive therapy selection

The Treatment domain (25%) includes adjunctive therapies, but the WCC exam never rewards a device-first mindset. A therapy is justified only if it is matched to the right wound problem, used within scope, documented, and reevaluated. The WCC credential is for licensed practitioners working under state practice acts and employer guidelines, so scope is embedded in every adjunct question.

Adjuncts surface when a wound is stalled despite sound wound bed preparation, often defined on the exam as failure to reduce surface area by roughly 40 to 50% over four weeks of appropriate care. Before reaching for a device, screen the modifiable barriers: perfusion, pressure/shear, infection or bioburden, edema, nutrition, glycemic control (an A1c above 7% and persistent hyperglycemia impair healing), medication effects (steroids, chemotherapy), and adherence.

Category map with safety screens

Adjunct category Exam purpose Safety and scope screen

Electrical stimulation (e-stim) Best evidence-supported adjunct for chronic stage 3/4 pressure injuries and select diabetic/venous ulcers Screen pacemaker/implanted electronic devices, electrodes near the heart or over malignancy, impaired sensation, pregnancy site, and policy clearance

Therapeutic/low-frequency ultrasound Selected tissue-healing or debridement protocols Confirm order, trained operator, avoid over malignancy, DVT, ischemic tissue, or active osteomyelitis

Topical antimicrobial (silver, iodine, PHMB, honey) Lowers local bioburden when local infection suspected Reassess at 2 weeks; prolonged use can be cytotoxic and mask failure to treat the cause

Collagen / matrix dressing Supports a moist, clean bed Do not place over unmanaged necrosis or heavy uncontrolled exudate

Cellular and/or tissue-based product (CTP, skin substitute) Selected nonhealing diabetic/venous ulcers Verify wound bed readiness, eligibility/payer rules, and documentation of failed standard care

Applied WCC scenario

A venous leg ulcer has been dressed with the same foam for six weeks, measurements are unchanged, and edema is uncontrolled. The best next step is not a costly matrix product. Reassess compression appropriateness and arterial status, exudate, infection signs, nutrition, and adherence, then correct the cause before adding an adjunct. Adding a skin substitute over an edematous, noncompressed limb wastes resources and still will not heal.

Electrical stimulation and ultrasound stems hide contraindication clues. An implanted cardiac device, electrodes over the heart, malignancy in the field, impaired protective sensation, active DVT, untreated osteomyelitis, or inability to report discomfort can flip the answer toward pause-and-verify. When safety data are incomplete, choose the option that checks policy and obtains clearance rather than the most aggressive device option.

Topical adjuncts carry their own trap. A silver or iodine dressing helps when local infection or critical colonization is present, but indefinite routine use damages healthy fibroblasts and hides an untreated cause. Reassess antimicrobials at about two weeks. Growth factors and CTPs fail on a dry, necrotic, ischemic, or still-pressured wound.

Documentation

Link the adjunct to a measurable goal: why chosen, baseline wound size and tissue, the contraindication review, education, tolerance, product/device used, settings, and the planned reassessment point. The exam favors objective reassessment because Re-Evaluation (16%) is its own domain.

Exam traps

The most advanced-sounding answer is not automatically correct; new odor, fever, rising pain, ischemic signs, or undermining points to infection or vascular workup and referral, not an added device.

Forgetting the implanted-device and malignancy screens for e-stim and ultrasound.

Treating advanced therapy as a substitute for diagnosis, source control, or prevention.

How electrical stimulation and ultrasound actually work

Electrical stimulation is the single adjunct with the strongest evidence base in chronic wound guidelines, which is why it appears more than its share on the exam. It applies a low-level current through electrodes to mimic the skin's natural bioelectric "current of injury," attracting reparative cells (galvanotaxis), enhancing perfusion, and supporting epithelial migration. Common waveforms include high-volt pulsed current.

The treatment area, electrode placement, polarity, and number of sessions are provider-ordered and operator-applied, so a WCC scenario rarely asks you to set parameters; it asks whether the patient is a safe candidate and whether the wound is stalled despite good basic care.

Therapeutic ultrasound delivers acoustic energy that produces thermal or nonthermal (cavitation, microstreaming) effects to stimulate tissue repair, while low-frequency contact ultrasound can also assist debridement. Avoid ultrasound over malignancy, active deep vein thrombosis, ischemic tissue, untreated osteomyelitis, the gravid uterus, and near electronic implants. As with e-stim, when the stem omits clearance for one of these conditions, the safest answer pauses to verify.

Cellular and tissue-based products and matrix dressings

Cellular and/or tissue-based products (skin substitutes) and collagen matrices are high-cost adjuncts reserved for diabetic or venous ulcers that have failed roughly four weeks of optimized standard care, including offloading or compression. The wound bed must be clean, adequately perfused, and free of clinical infection before placement, and documentation of failed standard care is usually required for payer approval. Placing a matrix on a necrotic, ischemic, infected, or still-pressured wound wastes the product and delays healing, which is the recurring exam lesson: optimize the basics and confirm readiness before escalating.

Always tie the adjunct to a measurable goal and a defined reassessment interval so the Re-Evaluation domain is satisfied.